Immunology and immunotherapy in breast cancer

Immuno-oncology is a rapidly developing field in medicine. Drug combination therapies have already been studied in many clinical trials on various tumor types. In recent years, a checkpoint inhibition therapy with monoclonal antibodies targeting PD-1 and its ligand PD-L1 has been developed. Breast c...

Full description

Bibliographic Details

Published in:	Cancer biology & medicine Vol. 19; no. 5; pp. 609 - 618
Main Authors:	Semiglazov, Vladimir, Tseluiko, Andrey, Kudaybergenova, Asel, Artemyeva, Anna, Krivorotko, Petr, Donskih, Roman
Format:	Journal Article
Language:	English
Published:	China Petrov National Medicine Cancer-Research Center Ministry of Health,Saint-Petersburg 197758,Russia 09-06-2022 Compuscript China Anti-Cancer Association
Subjects:	breast cancer immunotherapy pd-1 pd-l1 Review tumor-infiltrating lymphocytes PD-L1 tumor-infiltrating lymphocytes Breast cancer PD-1 immunotherapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!